COMP <GO>
ICHR vs PLAB // RSI-14 & 200D SMA MOMENTUM
Ichor Holdings (NASDAQ) VS. Photronics Inc. (NASDAQ) • 15-METRIC TALLY: ICHR 1
— PLAB 9
▲ RSI-14 & 200D SMA MOMENTUM LEADER: PLAB
LAST: $42.43 (-1.51%) • MKT CAP: $1.59B
rsi-technicals
40.6
LAST: $29.12 (-0.75%) • MKT CAP: $1.72B
rsi-technicals
50.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ICHR VS. PLAB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ICHR | PLAB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 9.30% | 35.30% | -26.00 | PLAB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -4.50% | 24.60% | -29.10 | PLAB | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 3.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.40% | 3.47% | -3.87 | PLAB | /fcf-yield <GO> |
| Operating Margin | -4.10% | 24.50% | -28.60 | PLAB | /operating-margins <GO> |
| Net Profit Margin | -5.60% | 16.10% | -21.70 | PLAB | /net-margins <GO> |
| Revenue Growth (YoY) | 11.60% | -2.00% | +13.60 | ICHR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.84 | 5.97 | -1.13 | PLAB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | PLAB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 40.6 | 50.7 | -10.10 | PLAB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 11.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.59B | $1.72B | -$128.8M | PLAB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ICHR REV | PLAB REV | ICHR GROSS % | PLAB GROSS % | ICHR FCF | PLAB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $947.7M | $849.3M | 9.3% | 35.3% | -$6.3M | $59.7M |
| FY 2024 | $849.0M | $866.9M | 12.2% | 36.4% | $10.2M | $130.5M |
| FY 2023 | $811.1M | $892.1M | — | — | $57.6M | $302.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ICHR // BETA —
PLAB // BETA —